{
    "organizations": [],
    "uuid": "69648103cb09cea5448b5e485bc67b39e6f242ec",
    "author": "",
    "url": "https://www.reuters.com/article/brief-nymox-announces-us-nda-for-fexapot/brief-nymox-announces-u-s-nda-for-fexapotide-for-bph-idUSFWN1PV16Y",
    "ord_in_thread": 0,
    "title": "BRIEF-Nymox Announces U.S. NDA For Fexapotide For BPH",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 5, 2018 / 6:18 PM / in 32 minutes BRIEF-Nymox Announces U.S. NDA For Fexapotide For BPH Reuters Staff \nFeb 5 (Reuters) - Nymox Pharmaceutical Corp: * NYMOX ANNOUNCES US NDA FOR FEXAPOTIDE FOR BPH \n* SAYS ‍RECENTLY HAD A PRE-NDA MEETING WITH FDA; NDA FOR FEXAPOTIDE FOR BPH​ WILL BE SUBMITTED LATER IN 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-02-05T20:18:00.000+02:00",
    "crawled": "2018-02-05T20:45:21.027+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "announces",
        "nda",
        "fexapotide",
        "bph",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "nymox",
        "pharmaceutical",
        "corp",
        "nymox",
        "announces",
        "u",
        "nda",
        "fexapotide",
        "bph",
        "say",
        "meeting",
        "fda",
        "nda",
        "fexapotide",
        "submitted",
        "later",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}